How Did Cochlear (ASX:COH) Shares Trade During the Latest ASX Session?

Sonal Goyal

14 July 2026 02:07 PM AEST

How Did Cochlear (ASX:COH) Shares Trade During the Latest ASX Session?

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

Cochlear shares advanced 1.48% during the latest ASX trading session.
The stock traded between AUD 120.575 and AUD 123.620 during the day.
Cochlear had a market capitalisation of AUD 7.95B during the session.

Cochlear Limited (ASX:COH) shares traded higher during the latest trading session, rising 1.48% to AUD 123.100 from the previous close of AUD 121.300. The healthcare company recorded steady trading activity as investors monitored movements in the stock throughout the session. During the day, the shares traded within a range of AUD 120.575 to AUD 123.620, reflecting intraday fluctuations before settling higher.

Trading Volume Remains Below Average

Cochlear recorded trading volume of 87,355 shares during the session, which was below its average daily trading volume of 582,745 shares. The bid price stood at AUD 123.100, while the offer price was AUD 123.150 during trading. Although the stock posted gains for the day, trading activity remained below its average level, indicating comparatively lighter participation than usual.

Stock Trades Within Its 52-Week Range

The latest share price remained within Cochlear's 52-week trading range of AUD 88.740 to AUD 319.560. The stock traded well above its annual low while remaining below its highest level over the past year. Investors often monitor a stock's annual trading range alongside daily price movements to evaluate how current performance compares with historical levels.

Market Capitalisation and Valuation

Cochlear had a market capitalisation of approximately AUD 7.95B during the latest trading session. The company operates in the Health Care Equipment & Services industry group and has been listed on the Australian Securities Exchange since 4 December 1995. It has 65,398,917 ordinary fully paid shares on issue under ISIN AU000000COH5. Based on the latest available market data, the stock was trading at a price-to-earnings (P/E) ratio of 23.09.

Latest Trading Snapshot

The latest trading data showed Cochlear closing at AUD 123.100 after gaining 1.48% during the session. The stock traded between AUD 120.575 and AUD 123.620 while recording volume below its average daily level. With a market capitalisation of AUD 7.95B and a P/E ratio of 23.09, the company continued to trade within its established 52-week price range.

Key Risks

Healthcare sector sentiment may influence share price movements.
Market volatility can affect short-term trading performance.
Lower trading volumes may increase price fluctuations.
Valuation levels may change with earnings expectations.

Summary

Cochlear Limited (ASX:COH) shares rose 1.48% to AUD 123.100 during the latest trading session. The stock traded within an intraday range of AUD 120.575 to AUD 123.620 while recording trading volume below its average daily level. Cochlear had a market capitalisation of AUD 7.95B and a P/E ratio of 23.09, with the shares remaining within their 52-week trading range.

FAQs

Q:Why did Cochlear shares rise during the latest trading session?

A:Cochlear shares gained 1.48% to AUD 123.100 based on the latest trading activity recorded on the Australian Securities Exchange.

Q:What was Cochlear's trading range during the session?

A:Cochlear shares traded between AUD 120.575 and AUD 123.620 during the latest ASX trading session.

Q:What was Cochlear's market capitalisation?

A:Cochlear had a market capitalisation of approximately AUD 7.95B based on the latest available market data.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.